Urine Testing in a Local Drug and Alcohol Service: How Has the COVID-19 Pandemic Affected the Frequency of Urine Testing in Patients With Opiate Addiction?
AimsWhen a dependant opiate user seeks help from a substance misuse service, it is vital that some form of drug testing is conducted. This is commonly a urine test and will show the patient's drug use over recent days and is used as a basis to guide treatment. All patients should have a urine s...
Gespeichert in:
Veröffentlicht in: | BJPsych open 2022-06, Vol.8 (S1), p.S85-S86 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S86 |
---|---|
container_issue | S1 |
container_start_page | S85 |
container_title | BJPsych open |
container_volume | 8 |
creator | Barker, John Lagundoye, Olawale Nield, Thomas |
description | AimsWhen a dependant opiate user seeks help from a substance misuse service, it is vital that some form of drug testing is conducted. This is commonly a urine test and will show the patient's drug use over recent days and is used as a basis to guide treatment. All patients should have a urine sample collected and tested on the same day as their initial appointment, however, we hypothesised that the switch to remote consultations would have reduced the number of urine tests conducted post-pandemic.MethodsAll the patients initially assessed by the substance misuse services for treatment of opiate addiction within the Sheffield Health and Social Care NHS Foundation Trust between 01/03/19 (1 year prior to the pandemic) and 01/03/21 (one year after the pandemic).The resultant sample contained 1403 patients: 739 patients were referred to Sheffield substance misuse services prior to the start of the COVID-19 pandemic; 664 patients were referred to Sheffield substance misuse services during or after the start of the COVID-19 pandemic.An algorithm was developed to allow interrogation of the electronic notes to record whether or not urine samples were taken and recorded in the relevant section of the patient's electronic record. This information was then transferred to an Excel spreadsheet.ResultsThe proportion of patients who had a urine test on the same day as their initial appointment was significantly higher in the year prior to the pandemic (79.0%) than the subsequent year (35.8%).Conclusion36% of the sample in the year subsequent to the pandemic had a urine test the day after their initial assessment, rather than on the same day. This delay in urine analysis can be attributed to the large number of initial appointments being conducted via telephone during the COVID-19 pandemic. This led to a delay in getting patients into clinic to give a urine sample. However, the remaining 64% of patients had no sample recorded in their notes in the appropriate proforma. Suggestions for improvement are to include a session on urinalysis as part of the weekly CPD to drive an improvement in this score back to pre-pandemic levels. |
doi_str_mv | 10.1192/bjo.2022.276 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9378221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1192_bjo_2022_276</cupid><sourcerecordid>2678242091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1976-f0879a4350e5413144c618bbb80bc4d61635fabedc06e9c82772b895d4fac6803</originalsourceid><addsrcrecordid>eNptkcFuEzEQhleISlSlNx5gJK5ssL1ee5cDKEopqRQplWjhaHm9s4mjjR1sp6jPwsvi0AiK2tOMNN_884_-onhDyYTSlr3vNn7CCGMTJsWL4pSRWpRcMv7yUf-qOI9xQwihteSy4afFr9tgHcINxmTdCqwDDQtv9AgXYb8C7XqYjsav_QhfMdxZgx9g7n_CXEdIa4TZ8tvVRUlbuM4obq2B6TCgSdj_GV8G_LFHZ-7BD_Dk1LVOFl2K8N2mNSx3VieEad9bk6x3n14XJ4MeI54f61lxe_n5ZjYvF8svV7PpojS0laIcSCNbzauaYM1pRTk3gjZd1zWkM7wXVFT1oDvsDRHYmoZJybqmrXs-aCMaUp0VHx90d_tum7FsKehR7YLd6nCvvLbq_4mza7Xyd6qtZMMYzQJvjwLB53djUhu_Dy57VkxkhDPSHqh3D5QJPsaAw98LlKhDhCpHqA4RqhxhxidHXG-7YPsV_lN9duE3fuWeHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678242091</pqid></control><display><type>article</type><title>Urine Testing in a Local Drug and Alcohol Service: How Has the COVID-19 Pandemic Affected the Frequency of Urine Testing in Patients With Opiate Addiction?</title><source>Cambridge Journals Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Barker, John ; Lagundoye, Olawale ; Nield, Thomas</creator><creatorcontrib>Barker, John ; Lagundoye, Olawale ; Nield, Thomas</creatorcontrib><description>AimsWhen a dependant opiate user seeks help from a substance misuse service, it is vital that some form of drug testing is conducted. This is commonly a urine test and will show the patient's drug use over recent days and is used as a basis to guide treatment. All patients should have a urine sample collected and tested on the same day as their initial appointment, however, we hypothesised that the switch to remote consultations would have reduced the number of urine tests conducted post-pandemic.MethodsAll the patients initially assessed by the substance misuse services for treatment of opiate addiction within the Sheffield Health and Social Care NHS Foundation Trust between 01/03/19 (1 year prior to the pandemic) and 01/03/21 (one year after the pandemic).The resultant sample contained 1403 patients: 739 patients were referred to Sheffield substance misuse services prior to the start of the COVID-19 pandemic; 664 patients were referred to Sheffield substance misuse services during or after the start of the COVID-19 pandemic.An algorithm was developed to allow interrogation of the electronic notes to record whether or not urine samples were taken and recorded in the relevant section of the patient's electronic record. This information was then transferred to an Excel spreadsheet.ResultsThe proportion of patients who had a urine test on the same day as their initial appointment was significantly higher in the year prior to the pandemic (79.0%) than the subsequent year (35.8%).Conclusion36% of the sample in the year subsequent to the pandemic had a urine test the day after their initial assessment, rather than on the same day. This delay in urine analysis can be attributed to the large number of initial appointments being conducted via telephone during the COVID-19 pandemic. This led to a delay in getting patients into clinic to give a urine sample. However, the remaining 64% of patients had no sample recorded in their notes in the appropriate proforma. Suggestions for improvement are to include a session on urinalysis as part of the weekly CPD to drive an improvement in this score back to pre-pandemic levels.</description><identifier>ISSN: 2056-4724</identifier><identifier>EISSN: 2056-4724</identifier><identifier>DOI: 10.1192/bjo.2022.276</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Coronaviruses ; COVID-19 ; Narcotics ; Pandemics ; Patients ; Poster Presentations ; Quality Improvement ; Urine</subject><ispartof>BJPsych open, 2022-06, Vol.8 (S1), p.S85-S86</ispartof><rights>Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists</rights><rights>Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378221/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S2056472422002769/type/journal_article$$EHTML$$P50$$Gcambridge$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,23299,27903,27904,53769,53771,55782</link.rule.ids></links><search><creatorcontrib>Barker, John</creatorcontrib><creatorcontrib>Lagundoye, Olawale</creatorcontrib><creatorcontrib>Nield, Thomas</creatorcontrib><title>Urine Testing in a Local Drug and Alcohol Service: How Has the COVID-19 Pandemic Affected the Frequency of Urine Testing in Patients With Opiate Addiction?</title><title>BJPsych open</title><addtitle>BJPsych open</addtitle><description>AimsWhen a dependant opiate user seeks help from a substance misuse service, it is vital that some form of drug testing is conducted. This is commonly a urine test and will show the patient's drug use over recent days and is used as a basis to guide treatment. All patients should have a urine sample collected and tested on the same day as their initial appointment, however, we hypothesised that the switch to remote consultations would have reduced the number of urine tests conducted post-pandemic.MethodsAll the patients initially assessed by the substance misuse services for treatment of opiate addiction within the Sheffield Health and Social Care NHS Foundation Trust between 01/03/19 (1 year prior to the pandemic) and 01/03/21 (one year after the pandemic).The resultant sample contained 1403 patients: 739 patients were referred to Sheffield substance misuse services prior to the start of the COVID-19 pandemic; 664 patients were referred to Sheffield substance misuse services during or after the start of the COVID-19 pandemic.An algorithm was developed to allow interrogation of the electronic notes to record whether or not urine samples were taken and recorded in the relevant section of the patient's electronic record. This information was then transferred to an Excel spreadsheet.ResultsThe proportion of patients who had a urine test on the same day as their initial appointment was significantly higher in the year prior to the pandemic (79.0%) than the subsequent year (35.8%).Conclusion36% of the sample in the year subsequent to the pandemic had a urine test the day after their initial assessment, rather than on the same day. This delay in urine analysis can be attributed to the large number of initial appointments being conducted via telephone during the COVID-19 pandemic. This led to a delay in getting patients into clinic to give a urine sample. However, the remaining 64% of patients had no sample recorded in their notes in the appropriate proforma. Suggestions for improvement are to include a session on urinalysis as part of the weekly CPD to drive an improvement in this score back to pre-pandemic levels.</description><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Narcotics</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Poster Presentations</subject><subject>Quality Improvement</subject><subject>Urine</subject><issn>2056-4724</issn><issn>2056-4724</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>IKXGN</sourceid><sourceid>BENPR</sourceid><recordid>eNptkcFuEzEQhleISlSlNx5gJK5ssL1ee5cDKEopqRQplWjhaHm9s4mjjR1sp6jPwsvi0AiK2tOMNN_884_-onhDyYTSlr3vNn7CCGMTJsWL4pSRWpRcMv7yUf-qOI9xQwihteSy4afFr9tgHcINxmTdCqwDDQtv9AgXYb8C7XqYjsav_QhfMdxZgx9g7n_CXEdIa4TZ8tvVRUlbuM4obq2B6TCgSdj_GV8G_LFHZ-7BD_Dk1LVOFl2K8N2mNSx3VieEad9bk6x3n14XJ4MeI54f61lxe_n5ZjYvF8svV7PpojS0laIcSCNbzauaYM1pRTk3gjZd1zWkM7wXVFT1oDvsDRHYmoZJybqmrXs-aCMaUp0VHx90d_tum7FsKehR7YLd6nCvvLbq_4mza7Xyd6qtZMMYzQJvjwLB53djUhu_Dy57VkxkhDPSHqh3D5QJPsaAw98LlKhDhCpHqA4RqhxhxidHXG-7YPsV_lN9duE3fuWeHw</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Barker, John</creator><creator>Lagundoye, Olawale</creator><creator>Nield, Thomas</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20220601</creationdate><title>Urine Testing in a Local Drug and Alcohol Service: How Has the COVID-19 Pandemic Affected the Frequency of Urine Testing in Patients With Opiate Addiction?</title><author>Barker, John ; Lagundoye, Olawale ; Nield, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1976-f0879a4350e5413144c618bbb80bc4d61635fabedc06e9c82772b895d4fac6803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Narcotics</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Poster Presentations</topic><topic>Quality Improvement</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barker, John</creatorcontrib><creatorcontrib>Lagundoye, Olawale</creatorcontrib><creatorcontrib>Nield, Thomas</creatorcontrib><collection>Cambridge Journals Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Psychology</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BJPsych open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barker, John</au><au>Lagundoye, Olawale</au><au>Nield, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urine Testing in a Local Drug and Alcohol Service: How Has the COVID-19 Pandemic Affected the Frequency of Urine Testing in Patients With Opiate Addiction?</atitle><jtitle>BJPsych open</jtitle><addtitle>BJPsych open</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>8</volume><issue>S1</issue><spage>S85</spage><epage>S86</epage><pages>S85-S86</pages><issn>2056-4724</issn><eissn>2056-4724</eissn><abstract>AimsWhen a dependant opiate user seeks help from a substance misuse service, it is vital that some form of drug testing is conducted. This is commonly a urine test and will show the patient's drug use over recent days and is used as a basis to guide treatment. All patients should have a urine sample collected and tested on the same day as their initial appointment, however, we hypothesised that the switch to remote consultations would have reduced the number of urine tests conducted post-pandemic.MethodsAll the patients initially assessed by the substance misuse services for treatment of opiate addiction within the Sheffield Health and Social Care NHS Foundation Trust between 01/03/19 (1 year prior to the pandemic) and 01/03/21 (one year after the pandemic).The resultant sample contained 1403 patients: 739 patients were referred to Sheffield substance misuse services prior to the start of the COVID-19 pandemic; 664 patients were referred to Sheffield substance misuse services during or after the start of the COVID-19 pandemic.An algorithm was developed to allow interrogation of the electronic notes to record whether or not urine samples were taken and recorded in the relevant section of the patient's electronic record. This information was then transferred to an Excel spreadsheet.ResultsThe proportion of patients who had a urine test on the same day as their initial appointment was significantly higher in the year prior to the pandemic (79.0%) than the subsequent year (35.8%).Conclusion36% of the sample in the year subsequent to the pandemic had a urine test the day after their initial assessment, rather than on the same day. This delay in urine analysis can be attributed to the large number of initial appointments being conducted via telephone during the COVID-19 pandemic. This led to a delay in getting patients into clinic to give a urine sample. However, the remaining 64% of patients had no sample recorded in their notes in the appropriate proforma. Suggestions for improvement are to include a session on urinalysis as part of the weekly CPD to drive an improvement in this score back to pre-pandemic levels.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><doi>10.1192/bjo.2022.276</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2056-4724 |
ispartof | BJPsych open, 2022-06, Vol.8 (S1), p.S85-S86 |
issn | 2056-4724 2056-4724 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9378221 |
source | Cambridge Journals Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Coronaviruses COVID-19 Narcotics Pandemics Patients Poster Presentations Quality Improvement Urine |
title | Urine Testing in a Local Drug and Alcohol Service: How Has the COVID-19 Pandemic Affected the Frequency of Urine Testing in Patients With Opiate Addiction? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A10%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urine%20Testing%20in%20a%20Local%20Drug%20and%20Alcohol%20Service:%20How%20Has%20the%20COVID-19%20Pandemic%20Affected%20the%20Frequency%20of%20Urine%20Testing%20in%20Patients%20With%20Opiate%20Addiction?&rft.jtitle=BJPsych%20open&rft.au=Barker,%20John&rft.date=2022-06-01&rft.volume=8&rft.issue=S1&rft.spage=S85&rft.epage=S86&rft.pages=S85-S86&rft.issn=2056-4724&rft.eissn=2056-4724&rft_id=info:doi/10.1192/bjo.2022.276&rft_dat=%3Cproquest_pubme%3E2678242091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2678242091&rft_id=info:pmid/&rft_cupid=10_1192_bjo_2022_276&rfr_iscdi=true |